Half-year Report

RNS Number : 2106O
NB Global Floating Rate Income Fund
17 August 2017
 

 

NB GLOBAL FLOATING RATE INCOME FUND LIMITED

Unaudited Consolidated Interim Financial Statements

 

For the six months ended 30 June 2017

 

COMPANY OVERVIEW  

 

Features

 

NB Global Floating Rate Income Fund Limited (the "Company")

The Company is a closed-ended investment company incorporated and registered in Guernsey on 10 March 2011 with registered number 53155. The Company is governed under the provisions of the Companies (Guernsey) Law, 2008 as amended (the "Law"), and the Registered Collective Investment Scheme Rules 2015 issued by the Guernsey Financial Services Commission. It is a non-cellular Company limited by shares and has been declared by the Guernsey Financial Services Commission to be a registered closed-ended collective investment scheme. On 20 April 2011, the Company was admitted to the Official List of the U.K. Listing Authority with a premium listing trading on the Main Market of the London Stock Exchange ("LSE"). The Company was admitted to the FTSE 250 in March 2012.

 

Alternative Investment Fund Manager ("AIFM") and Manager

Investment management services are provided to the Company by Neuberger Berman Investment Advisers LLC (the "AIFM") and Neuberger Berman Europe Limited (the "Manager"), collectively the "Investment Manager". The AIFM is responsible for risk management and discretionary management of the Company's portfolio and the Manager provides certain administrative services to the Company.

 

Investment Objective

The Company's investment objective is to provide its shareholders with regular dividends, at levels that are sustainable, whilst preserving the capital value of its investment portfolio, utilising the investment skills of the Investment Manager.

 

Investment Policy

To pursue its investment objective, the Company invests mainly in floating rate senior secured loans issued in United States Dollars ("U.S. Dollars"), Pound Sterling and Euros by primarily North American and European Union corporations, partnerships and other business issuers. These loans are at the time of investment often non-investment grade. The Company may also make investments in senior bonds on an opportunistic basis if the Investment Manager believes that such investments are attractively valued up to a maximum in aggregate of 20% of the net asset value at the time of investment. The Company considers debt instruments to be non-investment grade if, at the time of investment, they are rated below the four highest categories (Aaa, Aa, A and Baa) by at least two independent credit ratings agencies or, if unrated, are deemed by the Investment Manager to be of comparable quality. 

 

The Company will generally seek to focus on loans of issuers that the Investment Manager believes have the ability to generate cash flow through a full business cycle, maintain adequate liquidity, possess an enterprise value in excess of senior debt and have access to both debt and equity capital.

 

Capital Structure

As at 30 June 2017 the Company's share capital comprised 1,087,069,776 Sterling Ordinary Shares of no par value (of which 75,000,000 were held in treasury) and 45,729,127 U.S. Dollar Ordinary Shares of no par value (of which 1,342,627 were held in treasury).

 

For the purposes of efficient portfolio management, the Company has established a wholly-owned Luxembourg incorporated subsidiary, NB Global Floating Rate Income Fund (Lux) 1 S.à.r.l. which in turn holds a wholly-owned subsidiary, NB Global Floating Rate Income Fund (Lux) 2 S.à.r.l. Part of the portfolio of the Company is held through NB Global Floating Rate Income Fund (Lux) 2 S.à.r.l. All references to the Company in this document refer to the Company together with its wholly-owned Luxembourg subsidiaries.

 

Non-Mainstream Pooled Investments

The Company currently conducts its affairs so that the shares issued by the Company can be recommended by Independent Financial Advisers to ordinary retail investors in accordance with the Financial Conduct Authority's ("FCA") rules in relation to non-mainstream investment products and intends to continue to do so for the foreseeable future.

 

The Company's shares are excluded from the FCA's restrictions which apply to non-mainstream investment products because they are shares in an investment company, which if it were domiciled in the United Kingdom, would qualify as an investment trust.

 

Company Numbers

 

Sterling Ordinary Shares ("NBLS")

LSE ISIN code: GG00B3KX4Q34

Bloomberg code: NBLS:LN

 

U.S. Dollar Ordinary Shares ("NBLU")

LSE ISIN code: GG00B3P7S359

Bloomberg code: NBLU:LN

 

Legal Entity Identifier

549300P4FSBHZFALLG04

 

Dividends

Paid quarterly in respect of each calendar quarter.

Rolling 12 month dividend yield (based on the previous four quarterly dividends paid and share price as at 30 June 2017):

 

·              Sterling Ordinary Shares - 3.88%

·              U.S. Dollar Ordinary Shares - 3.83%

 

Website

www.nbgfrif.com

 

STRATEGIC REVIEW

 

Financial Highlights

 

Key Figures

 

 

 

 

(U.S. Dollars, except per share data)

As at 30 June 2017

As at 31 December 2016

 

 

 

Net Asset Value

 

 

          - Sterling Ordinary Shares

$1,280.1

$1,228.2

          - U.S. Dollar Ordinary Shares 1

$43.9

$37.8

 

 

 

Net Asset Value per share

 

 

          - Sterling Ordinary Shares

£0.9737

£0.9787

          - U.S. Dollar Ordinary Shares

$0.9883

$0.9881

 

 

 

Investments

$1,321.20

$1,256.9

 

 

 

Cash and Cash Equivalents

$35.4

$58.8

 

 

 

12 month rolling dividend yield

 

 

- Sterling Ordinary Shares 2

3.88%

4.18%

- U.S. Dollar Ordinary Shares 2

3.83%

4.12%

 

 

 

Share price

 

 

- Sterling Ordinary Shares

£0.9490

£0.9690

- U.S. Dollar Ordinary Shares

$0.9738

$0.9875

 

 

 

Discount to Net Asset Value

 

 

- Sterling Ordinary Shares

(2.54%)

(0.99%)

- U.S. Dollar Ordinary Shares

(1.47%)

(0.06%)

 

 

 

Total Return 3

 

 

- Sterling Ordinary Shares

1.27%

8.17%

- U.S. Dollar Ordinary Shares

1.81%

8.41%

 

 

 

Total Expense Ratio 4

 

 

- Sterling Ordinary Shares

0.46%

0.95%

- U.S. Dollar Ordinary Shares

0.49%

0.93%

 

1 In the six months to 30 June 2017, the Company re-issued 1,630,000 U.S. Dollar Ordinary Shares for gross consideration of $1.66 million.

 

2 The 30 June 2017 dividend yield is presented on an annual basis and calculated on the four quarterly dividends paid up to 30 June 2017. The 2016 comparative relates to dividends paid during the year from 1 January 2016 to 31 December 2016.

3 The total return is the NAV return per share plus dividends paid during the period. 2017 figures related to the period 1 January 2017 to 30 June 2017 while 2016 comparative relates to the year 1 January 2016 to 31 December 2016.

4 Management  fees and all other operating expenses expressed as a percent of average net assets. 2017 figures relate to expenses during the period 1 January 2017 to 30 June 2017, expressed as a percentage of the average daily net assets during the same period.  2016 figures relate to expenses during the period 1 January 2016 to 31 December 2016, expressed as a percentage of the average daily net assets during the same period.

 

 

Chairman's Statement

 

Dear Shareholder,

 

It is my pleasure to present to you the Interim Report of NB Global Floating Rate Income Fund Limited for the six months ended 30 June 2017.

 

Portfolio and Company Performance

 

2017 is proving another eventful year to date with the surprise result of the United Kingdom ("UK") General Election which returned a hung parliament and the formal filing of Article 50 on 29 March 2017 as the UK Government prepares to leave the European Union ("EU").  United States' ("U.S.") and European senior secured floating rate loans continue to perform well during the period, as fears over increasing default rates failed to materialise and the defaults that were seen in the market came in easily identifiable sectors such as commodities, reinforcing senior secured loans' credentials as a stable and resilient asset class with attractive risk-adjusted return characteristics.

 

The Board remains satisfied with the performance of the Company and the progress made by the Investment Manager during the period with the inclusion of dividends declared during the period, the Company's total return per share was 1.27% for the Sterling Ordinary Shares and 1.81% for the U.S. Dollar Ordinary Shares. During the same period the Company's share price return was -2.06% per Sterling Ordinary Share and -1.39% per U.S. Dollar Share.

 

At the start of the year, the Company's U.S. Dollar Ordinary Shares had traded at a premium. Throughout this period the Board has addressed the premium in the U.S. Dollar Ordinary Shares by issuing 1,630,000 U.S. Dollar Ordinary Shares out of Treasury at a weighted average premium to net asset value ("NAV") of 3.023%.

 

Your Board notes that subsequent to the period ended 30 June 2017 there has been a widening of the Company's discount. As at the latest practicable date prior to publication of this report the Company's Sterling Ordinary Shares and U.S. Dollar Ordinary Shares trade at a discount of 2.52% and 1.83% respectively. This is disappointing given the solid underlying performance of the portfolio.

 

As at the latest practicable date prior to publication of this report, the Company's current dividend yield is 3.88% and 3.83% per Sterling Ordinary Share and U.S. Dollar Share respectively (calculated as the last four quarterly dividends expressed as a percentage of the share price). Your Board believes this represents attractive value on both an absolute and a risk-adjusted basis given the current low interest rate environment and taking account of the prudent investment approach taken by the Investment Manager. As at 30 June 2017, 93.44% of the Company's portfolio was invested in issuers with a credit rating of BBB, (8.18%), BB (45.02%) and B (40.24%), reflecting the Investment Manager's preference for higher quality issuers.

 

The portfolio remains fully invested, with a strong U.S. bias. As at 30 June 2017, 90.95% of the Company was invested in U.S. Dollar denominated assets, with 7.12% invested in Euro denominated assets and 1.93% in Sterling denominated assets (all excluding cash).  The Company's Sterling Ordinary Share class hedges all U.S. Dollar and Euro exposure back to Sterling. The Board does not currently expect volatility in the foreign exchange markets to impact materially on the Company's NAV.

 

Discount / Premium Management

 

During the six months to 30 June 2017 the Company's maximum (discount)/premium ranged between -2.6% and 2.6% per Sterling Ordinary Share and -1.6% and 6.5% per U.S. Dollar Share. Throughout the period the Board continued to address temporary imbalances between supply and demand in the Company's shares as necessary by re-issuing or buying back shares.In the period to 30 June 2017, the Company has not repurchased any of the Company's own shares.

 

Since the 30 June 2017, and up to the latest practicable date of writing, the Company has repurchased 6,175,954 Sterling Ordinary Shares and 334,649 U.S. Dollar Shares reflecting the widening of the Company's discount. Your Board will remain vigilant in its approach to both discount and premium control on behalf of shareholders and reaffirms its belief that it is undesirable for the Company's shares to trade at much wider than a 3% discount or premium in normal market conditions. Your Board is reassured that the Company is of sufficient size to pursue its buyback policy and whether these volatile periods of the cycle without being at risk of becoming subscale and having a material impact on the Company's ongoing expenses ratio.

 

Outlook for the remainder of the financial year

 

Your Board believes that the outlook for the remainder of 2017 remains positive for short duration asset classes such as senior secured floating rate loans. We believe that moderate U.S. economic growth will lead to continued interest rate hikes which should be constructive for senior floating rate loans. Your Board agrees with the Investment Manager that default rates will stay below historical levels and credit quality is expected to remain favourable, with low volatility compared to other risk asset classes.

 

At a portfolio level, your Board expects the continued impact of Brexit negotiations to be limited given the robust investment process the Investment Manager has always adopted and its positioning in better rated, performing issuers.

 

Your Board believes the Company continues to offer an attractive risk-adjusted return, and is satisfied with the Investment Manager's performance to date and strategy. The Investment Manager will continue to  update you on the Company's progress by way of the monthly fact sheets and Investment Manager updates.

 

I would like to close by thanking you for your commitment and support.

 

 

 

William Frewen

Chairman

16 August 2017

 

 

Investment Manager's Report

 

 

For the six months ended 30 June 2017, the total return of the Company was 2.21% gross of fees. Over the same period the S&P/LSTA Leveraged Loan Index (the "Index"), returned 1.91%.

 

Demand for loans was robust, with over $50 billion of inflows from collateralized loan obligation (CLO) managers and a further $20 billion from retail funds. For comparison, the first half of 2016 saw $26 billion of inflows from CLO managers, and $9.3 billion of outflows from retail funds. With such high levels of demand, institutional supply has failed to keep up, leading to a continuation of re-pricings within the loan market. Having said this, the second quarter saw the first 3 months of excess supply since Q1 of 2016, suggesting that the supply shortage may be coming to an end.

 

The par amount outstanding of the Index stood at $943 billion at 30 June 2017, having ended 2016 at $887 billion. The average bid during the period was 98.02, with 58.68% of issues priced at par or above, versus 68.31% at the end of the year. By principal amount the trailing 12 month U.S. default rate was 1.54% at the end of June, in line with the closing figure for 2016.

 

In Europe the S&P European Leveraged Loan Index ("ELLI") returned 2.65% year-to-date through 30 June 2017 (all numbers excluding currency) and the average bid finished at 99.50, up on the 98.62 as of the end of 2016. Demand was strong and CLO issuance totalled €8.3 billion through 30 June 2017, very much in-line with the €7.2 billion posted in the first half of 2016. The par amount outstanding of the ELLI ended the quarter at €118 billion, an increase on the €99 billion one year ago. By principal amount the trailing 12 month default for the ELLI was 2.20% at the end of June, down from 2.40% at the end of 2016.

 

The portfolio has remained very much weighted towards U.S. Dollar issuance, which accounted for 91% of the portfolio at the end of June. The bond allocation remained well below the 20% of NAV permitted, at 7.5%, as we remained focused on keeping duration low and limiting potential areas of volatility. We continued to allocate to better rated assets, and the BBB/BB weighting ended June at 53.2%.

 

Outlook

 

Our outlook for the loan market remains positive. Generally we feel that issuers are performing steadily, leverage is being controlled and cash cover metrics are strong. The market today is pricing in approximately a 1.77% imputed U.S. default rate, which is in line with our 2017 expectations of 1.5 - 2.5%. We believe that moderate U.S. economic growth will lead to continued interest rate hikes which should be constructive for senior floating rate loans. We continue to believe that loans will be attractive given the returns on offer, the expected low volatility compared to other risk asset classes and their senior secured nature.

 

 

 

Neuberger Berman Investment Advisers LLC                                  Neuberger Berman Europe Limited

16 August 2017                                                                                       16 August 2017

 

Portfolio Infirmation

 

 

Top 10 Issuers as at 30 June 2017 (excluding cash)

 

Issuer

Sector

Fair Value

Portfolio Weight

Valeant Pharmaceuticals

Drugs

27,587,290

2.09%

First Data

Business Equipment & Services

26,412,127

2.00%

Univision

Broadcast Radio & TV

15,977,413

1.21%

Intelsat

Telecommunications

15,076,803

1.14%

CenturyLink Inc

Telecommunications

14,667,751

1.11%

Endo Pharmaceutical

Drugs

 14,539,469

1.10%

TXU

Utilities

 20,905,442

1.58%

Reynolds

Containers & Glass

 14,000,572

1.06%

Wide Open West

Cable TV

 13,655,397

1.03%

Virgin Media

Cable TV

 13,333,317

1.00%

 

 

 

13.32%

 

 

 

Top 10 S&P Sector Breakdown (excluding cash)

 

http://www.rns-pdf.londonstockexchange.com/rns/2106O_-2017-8-16.pdf

Key Statistics as at 30 June 2017

 

Current Gross Portfolio Yield 1

4.53%

Number of Investments 

362

Number of Issuers

270

 

 

 

1 The Company's Current Gross Portfolio Yield is a market-value weighted average of the current yields of the holdings in the portfolio, calculated as the coupon (base rate plus spread) divided by current price. The calculation does not take into account any fees, fund expenses or sales charges paid, which would reduce the results. The Current Gross Portfolio Yield for the Company will fluctuate from month to month. The Current Gross Portfolio Yield should be regarded as an estimate of the Company's rate of investment income, and it will not equal the realised distribution rate for each share class.

 

Currency Breakdown

 

http://www.rns-pdf.londonstockexchange.com/rns/2106O_-2017-8-16.pdf

 

Rating Breakdown

 

http://www.rns-pdf.londonstockexchange.com/rns/2106O_-2017-8-16.pdf

 

Security Breakdown

 

http://www.rns-pdf.londonstockexchange.com/rns/2106O_-2017-8-16.pdf

GOVERNANCE

 

Interim Management Report and Director's Responsibility Statement

 

Principal Risks and Uncertainties

The principal risks of the Company are in the following areas:

·      macroeconomic conditions;

·      credit risk;

·      liquidity risk;

·      fund performance;

·      level of discount or premium; and

·      operational risk.

 

The Board reported on each of these principal risks and uncertainties in the Strategic Report of the Company's latest annual report and audited financial statement for the year ended 31 December 2016, which can be found on the Company's website at http://www.nbgfrif.com/pdf/NBGFRIF_annual_report_2016.pdf. The Board's view is that these risks remain appropriate for the remainder of 2017. A brief description of each of the Principal Risks are detailed below:

 

Macroeconimic Conditions

Macroeconomic conditions can change significantly and to the detriment of the portfolio or the Company causing a credit or liquidity risk to crystallise.

 

Credit Risk

The key risk for the Company remains credit risk i.e. that the Investment Manager buys a loan or bond of a particular Issuer and it does not perform as expected and either defaults on a payment or experiences a significant drop in the secondary market value.

 

Liquidity Risk

Liquidity risk is the risk that the Company will not be able to meet its obligations as and when these fall due.

 

Fund Performance

The Company's Investment performance could fall below its stated objective or peer group for a variety of reasons including market conditions.

 

Level of Discount or Premium

A discount or premium to NAV can occur for a variety of reasons, including market conditions or to the extent investors undervalue the management activities of the Investment Manager or discount their valuation methodology and judgment.

 

Operational Risk

Disruption to, or the failure of either the Investment Manager's, Administrator's or Sub- Administrator's accounting, dealings or payment systems, or the Custodian's records could prevent the accurate reporting or monitoring of the Company's financial position and the receipt or transmission of payments.

 

Going Concern

Having reassessed the principal risks, the Directors considered it appropriate to prepare the Unaudited Consolidated Interim Financial Statements (the "Financial Statements") on a going concern basis.

 

Related Party Transactions

Other than fees payable in the ordinary course of business, there have been no material transactions with related parties, which have affected the financial position or performance of the Company in the six month financial period to 30 June 2017. Additional related party disclosures are given in Note 3 and Note 4.

 

Directors' Responsibilities Statement

The Board of Directors confirms that, to the best of its knowledge:

 

The Financial Statements, which have been prepared in conformity with United States generally accepted accounting principles ("US GAAP") and the Financial Accounting Standards Board ("FASB"). Accounting Standards Codification ("ASC") 270' "Interim Reporting", gives a true and fair view of the assets, liabilities, financial position and profits/(losses) of the Company, as required by DTR 4.2.4R of the Disclosure Guidance and Transparency Rules ("DTR") of the FCA.

 

The combination of the Chairman's Statement, the Investment Manager's Report and this Interim Management Report meet the requirements of an Interim Management Report, and include a fair review of the information required by:

 

1. DTR 4.2.7R of the DTR, of the U.K.'s FCA, being an indication of important events that have occurred during the first six months of the year and their impact on the set of Financial Statements; and a description of the principal risks and uncertainties for the remaining six months of the year; and

 

2. DTR 4.2.8R of the DTR, of the U.K.'s FCA, being related party transactions that have taken place in the first six months of the current year and that have materially affected the financial position or performance of the Company during that period; and any material changes in the related party transactions described in the last annual report.

 

 

 

William Frewen                                                        Richard Battey

Chairman                                                               Director

16 August 2017                                                       16 August 2017

 

 

Independent review report to NB Global Floating Rate Income Fund Limited

 

 

Our conclusion

 

We have reviewed the accompanying condensed consolidated interim financial information of NB Global Floating Rate Income Fund Limited and its subsidiaries (the 'Group') as of 30 June 2017. Based on our review, nothing has come to our attention that causes us to believe that the accompanying condensed consolidated interim financial information is not prepared, in all material respects, in accordance with the Financial Accounting Standards Board Accounting Standards Codification 270, "Interim Reporting" and the Disclosure Guidance and Transparency Rules sourcebook of the United Kingdom's Financial Conduct Authority.

 

What we have reviewed

The accompanying condensed consolidated interim financial information comprise:

·      the Unaudited Consolidated Statement of Assets and Liabilities as of 30 June 2017;

·      the Unaudited Consolidated Condensed Schedule of Investments as of 30 June 2017;

·      the Unaudited Consolidated Statement of Operations for the six-month period then ended;

·      the Unaudited Consolidated Statement of Changes in Net Assets for the six-month period then ended;

·      the Unaudited Consolidated Statement of Cash Flows for the six-month period then ended; and

·      the notes, comprising a summary of significant accounting policies and other explanatory information.

The condensed consolidated interim financial information has been prepared in accordance with the Financial Accounting Standards Board Accounting Standards Codification 270, "Interim Reporting" and the Disclosure Guidance and Transparency Rules sourcebook of the United Kingdom's Financial Conduct Authority.

 

Our responsibilities and those of the directors

The Directors are responsible for the preparation and presentation of this condensed consolidated interim financial information in accordance with the Financial Accounting Standards Board Accounting Standards Codification 270, "Interim Reporting" and the Disclosure Guidance and Transparency Rules sourcebook of the United Kingdom's Financial Conduct Authority.

Our responsibility is to express a conclusion on this condensed consolidated interim financial information based on our review. This report, including the conclusion, has been prepared for and only for the company for the purpose of complying with the Disclosure Guidance and Transparency Rules sourcebook of the United Kingdom's Financial Conduct Authority and for no other purpose. We do not, in giving this conclusion, accept or assume responsibility for any other purpose or to any other person to whom this report is shown or into whose hands it may come save where expressly agreed by our prior consent in writing.

 

Scope of review

We conducted our review in accordance with International Standard on Review Engagements 2410, 'Review of interim financial information performed by the independent auditor of the entity' issued by the International Auditing and Assurance Standards Board. A review of interim financial information consists of making inquiries, primarily of persons responsible for financial and accounting matters, and applying analytical and other review procedures.

A review is substantially less in scope than an audit conducted in accordance with International Standards on Auditing and consequently does not enable us to obtain assurance that we would become aware of all significant matters that might be identified in an audit. Accordingly, we do not express an audit opinion.

 

We have read the other information contained in the Unaudited Consolidated Interim Financial Statements and considered whether it contains any apparent misstatements or material inconsistencies with the information in the interim financial statements.

 

PricewaterhouseCoopers CI LLP

Chartered Accountants

Guernsey, Channel Islands

16 August 2017   

 

 

 

(a)    The maintenance and integrity of the NB Global Floating Rate Income Fund Limited website is the responsibility of the directors; the work carried out by the auditors does not involve consideration of these matters and, accordingly, the auditors accept no responsibility for any changes that may have occurred to the financial statements since they were initially presented on the website.

(b)   Legislation in Guernsey governing the preparation and dissemination of financial statements may differ from legislation in other jurisdictions.

 

 

FINANCIAL STATEMENTS

 

Unaudited Consolidated Statement of Assets and Liabilities

 

 

As at 30 June 2017 and 31 December 2016

(Expressed in U.S. Dollars)

 

Notes

30 June 2017

 (Unaudited)

31 December 2016

(Audited)

 

Assets

 

 

 

Investments at fair value

(2017: cost of 1,318,060,273, 2016: cost of 1,262,575,676)

5

1,321,229,556

1,256,886,223

Cash and cash equivalents:

 

 

 

- Sterling

 

4,879,582

10,271,118

- Euro

 

7,643,159

20,030,923

- U.S. Dollar

 

22,869,534

28,527,585

Total cash and cash equivalents

 

35,392,275

58,829,626

 

 

1,356,621,831

1,315,715,849

Other assets

 

 

 

Receivables for investments sold

 

50,474,319

17,394,802

Interest receivable

 

3,461,087

4,777,061

Other receivables and prepayments

 

147,728

93,369

Derivative assets

5

2,098,135

15,225,146

Total other assets

 

56,181,269

37,490,378

Total assets

 

1,412,803,100

1,353,206,227

 

 

 

 

Liabilities

 

 

 

Payables for investments purchased

 

85,071,142

84,256,725

Payables to Investment Manager and affiliates

3

2,434,729

2,365,325

Derivative liabilities

5

961,634

-

Accrued expenses and other liabilities

3

413,419

541,645

Total liabilities

 

88,880,924

87,163,695

 

 

 

 

Total assets less liabilities

 

1,323,922,176

1,266,042,532

 

 

 

 

Share capital

9

1,692,078,755

1,690,371,848

Accumulated reserves

 

(368,156,579)

(424,329,316)

Total net assets

 

1,323,922,176

1,266,042,532

 

 

As at 30 June 2017

 

 

 

 

Net Asset Value

 

 

 

 

Number of Shares

 

 

 

 

NAV per Share

U.S. Dollar shareholding

 

 

 

 

 

 

          - Ordinary Shares

 

$43,866,243

 

44,386,500

 

$0.9883

Sterling shareholding

 

 

 

 

 

 

          - Ordinary Shares

 

£985,454,354

 

1,012,069,776

 

£0.9737

Sterling shareholding (in U.S.Dollars)

 

 

 

 

 

 

          - Ordinary Shares

 

$1,280,055,933

 

1,012,069,776

 

$1.2648

 

 

The Financial Statements were approved and authorised for issue by the Board of Directors on 16 August 2017, and signed on its behalf by:

 

 

 

 

 

William Frewen                                                                                        Richard Battey

Chairman                                                                                                   Director

 

 

 

 

The accompanying notes form an integral part of the consolidated financial statements.

 

Unaudited Consolidated Condensed Schedule of Investments

 

As at 30 June 2017  

(Expressed in U.S. Dollars)

 

 

Cost

Fair Value

Fair Value as %

of Net Assets

Portfolio of investments

 

 

 

Financial investments

 

 

 

-       Floating rate senior secured loans

1,226,808,193

1,226,954,139

92.68%

-       Fixed rate bonds

55,668,075

56,325,844

4.25%

-       Floating rate bonds

35,584,005

37,949,573

2.87%

Total financial investments

1,318,060,273

1,321,229,556

99.80%

 

 

 

 

Total portfolio of investments

1,318,060,273

1,321,229,556

99.80%

 Forwards

 

 

 

Euro to U.S. Dollar

-

180,008

0.02%

Sterling to U.S. Dollar

-

5,978,754

0.45%

U.S. Dollar to Euro

-

(4,862,911)

(0.37%)

U.S. Dollar to Sterling

-

(159,350)

(0.01%)

 

 

1,136,501

0.09%

 

 

 

 

 

 

 

Cost

Fair Value

Fair Value as %

of Net Assets

Geographic diversity of investment portfolio

 

 

 

 

 

 

 

Geographic diversity of investment portfolio

 

 

 

Australia/Oceania

              2,491,774

2,490,608

0.31%

Caribbean

            31,527,015

            33,615,573

2.54%

North America

       1,145,060,654

1,143,189,960

86.23%

Europe

          138,980,830

          141,933,415

10.72%

 

       1,318,060,273

       1,321,229,556

99.80%

 

 

 

As at 31 December 2016

(Expressed in U.S. Dollars)

Cost

Fair Value

Portfolio of investments

 

 

 

Financial investments

 

 

 

Floating rate senior secured loans

1,220,170,197

1,213,873,452

95.88%

Fixed rate bonds

6,416,388

6,410,344

0.51%

Floating rate bonds

35,989,091

36,602,427

2.89%

Total financial investments

1,262,575,676

1,256,886,223

99.28%

 

 

 

 

Total portfolio of investments

1,262,575,676

1,256,886,223

99.28%

 Forwards

 

 

 

U.S. Dollar to Euro

-

4,074,462

0.32%

Sterling to U.S. Dollar

-

11,564,568

0.91%

U.S. Dollar to Sterling

-

(148,744)

(0.01%)

Euro to Sterling

-

(94,613)

(0.01%)

Euro to U.S. Dollar

-

(170,527)

(0.01%)

 

15,225,146

1.20%

 

 

 

 

Cost

Fair Value

Fair Value as %

 of Net Assets

Geographic diversity of investment portfolio

 

 

 

North America

1,119,704,474

1,119,421,012

88.42

Australia/Oceania

4,070,889

4,148,949

0.33

Europe

138,800,313

133,316,262

10.53

 

1,262,575,676

1,256,886,223

99.28

 

 

As at 30 June 2017

(Expressed in U.S. Dollars)

 

 

30 June 2017

31 December 2016

 

(Unaudited)

(Audited)

Industry diversity of Investment Portfolio

Cost

Fair Value

Cost

Fair Value

Aerospace & Defence

 5,979,465

 5,994,170

6,010,397

6,072,357

Air Transport

 13,478,730

 13,458,697

14,994,162

15,097,483

Automotive

 13,826,552

 13,849,568

13,099,656

13,154,487

Broadcast Radio & Television

 37,005,631

 34,411,724

30,573,209

27,289,619

Business Equipment & Services

 152,634,983

 151,740,373

150,945,338

150,244,072

Building & Development

 44,993,635

 45,139,027

44,749,026

45,156,117

Cable & Satellite Television

 90,607,441

 91,989,333

85,850,028

83,782,756

Chemicals & Plastics

 26,632,494

 27,437,184

28,161,440

28,123,140

Conglomerates

 2,455,457

 2,450,193

3,200,104

3,202,547

Containers & Glass Products

 73,709,560

 74,270,974

81,055,964

81,141,060

Cosmetics/Toiletries

 6,509,702

 6,518,333

-

-

Drugs

 59,649,427

 61,004,267

69,848,569

70,837,534

Ecological Services & Equipment

 10,686,913

 10,735,765

10,761,054

10,897,919

Electronics/Electrical

 98,358,446

 97,652,852

107,678,600

106,903,155

Energy

-

-

2,241,650

2,289,800

Equipment Leasing

 8,684,676

 8,763,034

2,264,131

2,269,040

Financial Intermediaries

 61,275,951

 62,980,548

63,967,235

64,387,402

Food Products

 15,040,362

 14,652,053

21,853,184

20,349,684

Food Service

 28,138,303

 28,698,990

22,181,347

22,640,245

Food/Drug Retailers

 14,441,001

 14,400,463

11,386,389

11,250,561

Health Care

 104,324,261

 105,115,874

89,463,601

88,429,140

Hotels & Casinos

 80,695,761

 82,370,694

76,179,702

78,303,694

Industrial Equipment

 60,135,539

 59,605,598

50,180,235

49,284,624

Insurance

 7,978,206

 8,062,030

8,009,796

8,100,203

Leisure Goods/Activities/Movies

 35,947,043

 36,188,538

38,591,122

38,979,267

Oil & Gas

 24,716,090

 23,838,843

15,787,271

17,026,476

Publishing

 10,228,978

 10,282,142

5,423,978

5,503,203

Real Estate

-

-

844,138

844,544

Retailers (except food/ drug retailers)

 40,254,638

 39,738,533

62,415,601

60,059,477

Steel

 7,300,654

 7,372,297

11,535,856

11,669,916

Surface Transport

 12,102,852

 12,154,995

6,893,898

6,914,697

Telecommunications

 89,920,394

 90,403,139

56,584,506

55,980,742

Utilities

 80,347,127

 79,949,325

69,844,489

70,701,262

 

 1,318,060,272

 1,321,229,556

1,262,575,676

1,256,886,223

                                                                                                                                                                                 

 

As at 30 June 2017, issuers with the following investments comprised of greater than 1% of NAV (Excluding cash):

 

 

Securities

Country

Industry

Fair Value

%

 

 

 

 

 

VALEANT PHARMACEUTICALS

 

 

         27,587,290

2.09%

VALEANT PHARMACEUTICALS 5.875% 05/15/23 SR:REGS

Canada

Drugs

         19,005,683

1.44%

VALEANT PHARMACEUTICALS 6.500% 03/15/22 SR:144A

Canada

Drugs

           3,595,275

0.27%

VALEANT PHARMACEUTICALS 7.000% 03/15/24 SR:144A

Canada

Drugs

           3,550,019

0.27%

Valeant Pharmaceuticals T/L - F1

Canada

Drugs

           1,436,313

0.11%

 

 

 

 

 

FIRST DATA CORPORATION

 

 

         26,412,127

1.99%

First Data Corporation FIRST DATA 1L TL

United States

Business Equipment & Services

         19,227,275

1.45%

First Data Corporation

United States

Business Equipment & Services

           5,175,576

0.39%

First Data Corporation FIRST DATA 1L TL

United States

Business Equipment & Services

           2,009,276

0.15%

 

 

 

 

 

TXU

 

 

         20,905,442

1.58%

TXU/TCEH 10/16 Cov-Lite TLB

United States

Utilities

         11,469,477

0.87%

TXU Energy 1L TL

United States

Utilities

           6,806,975

0.51%

TXU/TCEH 10/16 Cov-Lite TLC

United States

Utilities

           2,628,990

0.20%

 

 

 

 

 

UNIVISION COMMUNICATIONS

 

 

         15,977,413

1.21%

Univision Communications Inc 1L TL-C5

United States

Broadcast Radio & Television

         15,977,413

1.21%

 

 

 

 

 

INTELSAT JACKSON

 

 

         15,076,803

1.14%

INTELSAT JACKSON T/L B2 30/06/2019

Luxembourg

Telecommunications

         15,076,803

1.14%

 

 

 

 

 

CENTURYLINK

 

 

         14,667,751

1.11%

CenturyLink 1L TL-B

United States

Telecommunications

         14,667,751

1.11%

 

 

 

 

 

ENDO

 

 

         14,539,469

1.10%

Endo Pharma 1L TL-B

United States

 Drugs

         11,686,369

0.88%

ENDO DAC/FIN LLC/FINCO 5.875% 10/15/24 SR:REGS

United States

 Drugs

           2,853,100

0.22%

 

 

 

 

 

REYNOLDS

 

 

         14,000,572

1.06%

Reynolds Group 1/17 (USD) TL

United States

Containers & Glass Products

         12,434,862

0.94%

REYNOLDS GRP ISS/  5.750% 10/15/20

United States

Containers & Glass Products

           1,565,710

0.12%

 

 

 

 

 

WIDE OPEN WEST

 

 

         13,655,397

1.04%

Wide Open West FINANCE LLC 1L   TL-B

United States

Cable & Satellite Television

           9,352,282

0.71%

Wide Open West 1L TL-B

United States

Cable & Satellite Television

           4,303,116

0.33%

 

 

 

 

 

VIRGIN MEDIA

 

 

         13,333,317

1.00%

Virgin Media (fka NTL Investment Holdings Ltd) 1L TL-J  GBP

United Kingdom

Cable & Satellite Television

           6,792,568

0.51%

VIRGIN MEDIA SECURED FIN 5.000% 04/15/27 SR:REGS

United Kingdom

Cable & Satellite Television

           3,341,549

0.25%

Virgin Media (fka NTL Investment Holdings Ltd) 1L TL-I

United Kingdom

Cable & Satellite Television

           3,199,200

0.24%

 

 

 

 

 

 

 

 

       176,155,581

13.32%

 

 

As at 31 December 2016, issuers with the following investments comprised of greater than 1% of NAV (Excluding cash):

 

Securities

Country

Industry

Fair Value

%

 

VALEANT PHARMACEUTICALS

 

 

33,740,844

2.67%

Valeant Pharmaceuticals T/L - F1

Canada

Drugs

33,740,844

2.67%

 

 

 

 

 

FIRST DATA CORPORATION

 

 

25,146,475

1.98%

First Data T/L (2021C New Dollar)

United States

Business Equipment & Services

19,811,573

1.56%

First Data 2022 C Dollar T/L

United States

Business Equipment & Services

5,334,902

0.42%

 

 

 

 

 

TXU

 

 

19,703,064

1.55%

TXU/TCEH 10/16 Cov-Lite TLB

United States

Utilities

11,768,911

0.93%

TXU Energy 1L TL-DIP

United States

Utilities

5,250,015

0.41%

TXU/TCEH 10/16 Cov-Lite TLC

United States

Utilities

2,684,138

0.21%

 

 

 

 

 

AVAGO TECHNOLOGIES

 

 

18,738,885

1.48%

Avago Technologies Tl

Cayman Islands

Electronics/Electrical

18,738,885

1.48%

 

 

 

 

 

CHS/COMMUNITY HEALTH INCREMENTAL

 

 

16,637,580

1.32%

CHS/Community Health Incremental 2021 Term H Loan

United States

Health Care

9,502,553

0.75%

CHS/Community Health Incremental 2019 Term G Loan

United States

Health Care

6,043,947

0.48%

CHS/Community Health Community Health Systems 1L TL-F1  (First-Lien)

United States

Health Care

1,091,080

0.09%

 

 

 

 

 

ENERGY TRANSFER EQUITY

 

 

15,510,094

1.23%

Energy Transfer Equity Tranche B T/L (First-Lien)

United States

Oil & Gas

10,103,973

0.80%

Energy Transfer Equity T/L C 12/02/2019

United States

Oil & Gas

5,406,121

0.43%

 

 

 

 

 

INTELSAT JACKSON

 

 

14,692,419

1.16%

Intelsat Jackson T/L B2 30/06/2019

Luxembourg

Telecommunications

14,692,419

1.16%

 

 

 

 

 

INFORMATION RESOURCES

 

 

 13,731,458

1.08%

Information Resources Inc. T/L B 26/09/2020

United States

Business Equipment & Services

 8,664,989

0.68%

Information Resources Inc. (Symphony IRI Group Inc.)

United States

Business Equipment & Services

 5,066,469

0.40%

 

 

 

 

 

ENDO PHARMA

 

 

13,489,003

1.07%

Endo Pharma T/L B-1

United States

Drugs

13,489,003

1.07%

 

 

 

 

 

BASS PRO SHOPS

 

 

12,676,368

1.00%

Bass Pro Shops 1L TL-B

United States

Retailers (except food /drug retailers)

8,543,700

0.67%

Bass Pro Shops Tranche B-1 T/L (First-Lien)

United States

Retailers (except food /drug retailers)

4,132,668

0.33%

 

 

 

 

 

REYNOLDS GROUP

 

 

12,641,463

1.00%

Reynolds Group (aka Beverage Packaging) T/L B-1 1st Lien

United States

Containers & Glass Products

12,641,463

1.00%

 

 

 

 

 

 

 

 

196,707,653

15.54%

 

 

 

As at 30 June 2017, the below were the largest 50 investments based on the NAV:

 

Securities

Country

Industry

 Fair value $

%

First Data Corporation 1L TL

United States

 Business Equipment & Services

           19,227,275

1.45%

Valeant Pharmaceuticals Term Loan - F1

Canada

 Drugs

           19,005,683

1.44%

Univision Communications Inc 1L TL-C5

United States

 Broadcast Radio & Television

           15,977,413

1.21%

INTELSAT JACKSON T/L B2 30/06/2019

Luxembourg

 Telecommunications

           15,076,803

1.14%

CenturyLink 1L TL-B

United States

 Telecommunications

           14,667,751

1.11%

Reynolds Group 1/17 (USD) TL

United States

 Containers & Glass Products

           12,434,862

0.94%

Endo Pharma 1L TL-B

United States

 Drugs

           11,686,369

0.88%

TXU/TCEH 10/16 Cov-Lite TLB

United States

 Utilities

           11,469,477

0.87%

IASIS Healthcare Corporation IASIS 1L TL

United States

 Health Care

           10,878,724

0.82%

Grifols WORLDWIDE 1L TL-B

United States

 Health Care

           10,106,454

0.76%

FORMULA ONE HLDGS LTD T/L 31/07/2021

Luxembourg

 Leisure Goods/Activities/Movies

             9,812,060

0.74%

Nautilus Power NAUTILUS POWER 1L TL-B

United States

 Utilities

             9,793,569

0.74%

TPF II POWER LLC T/L B 11/09/2021

United States

 Utilities

             9,772,027

0.74%

Dynegy Holdings Inc 1L

United States

 Utilities

             9,760,522

0.74%

Dell 1L TL

United States

 Electronics/Electrical

             9,666,824

0.73%

Pharmaceutical Product 5/17 Cov-Lite TL

United States

 Drugs

             9,610,748

0.73%

Sprint Communications  1L TL-B

United States

 Telecommunications

             9,598,921

0.73%

Charter Communications T/L I (12/16)

United States

 Cable & Satellite Television

             9,501,801

0.72%

Wide Open FINANCE LLC 1L   TL-B

United States

 Cable & Satellite Television

             9,352,282

0.71%

Cowlitz Tribal Gaming Authority Term Loan B

United States

 Hotels & Casinos

             9,307,350

0.70%

Verallia SA EUR 1L TL-

France

 Containers & Glass Products

             9,275,958

0.70%

FILTRATION GR CO 1ST LIEN T/L 13/11/2020

United States

 Industrial Equipment

             9,062,764

0.68%

CHS/Community Health Incremental 2021 Term H Loan

United States

 Health Care

             8,940,808

0.68%

Emerald Expositions Holdings NIELSEN BUSINESS MEDIA 1L TL-B

United States

 Leisure Goods/Activities/Movies

             8,497,275

0.64%

SYNIVERSE HOLDINGS T/L 10/04/2019

United States

 Telecommunications

             8,457,737

0.64%

Milacron LLC 1L TL-B

United States

 Industrial Equipment

             8,423,241

0.64%

Presidio 1L TL

United States

 Business Equipment & Services

             8,341,630

0.63%

Cablevision Systems Corp 1L TL-B

United States

 Cable & Satellite Television

             8,333,114

0.63%

Berlin Packaging 5/17 TLB

United States

 Containers & Glass Products

             8,131,858

0.61%

HCA Inc. 1L TL-B9

United States

 Health Care

             8,113,897

0.61%

DTZ Term B

United States

 Building & Development

             7,993,216

0.60%

TWIN RIVER MGT GRP T/L B 1L 30/06/2020

United States

 Hotels & Casinos

             7,930,034

0.60%

Scientific Games Corp 1L TL-B3

United States

 Hotels & Casinos

             7,925,729

0.60%

Datatel-Sophia LP 1L T

United States

 Electronics/Electrical

             7,922,441

0.60%

Eldorado Resorts  1L TL-B

United States

 Hotels & Casinos

             7,514,666

0.57%

Energy Transfer Equity 1L TL

United States

 Oil&Gas

             7,258,974

0.55%

Team Health  Inc. 1L TL-B

United States

 Health Care

             7,037,854

0.53%

CROSBY WORLDWIDE LIMITED T/L 06/11/2020

United States

 Industrial Equipment

             7,030,266

0.53%

99 CENTS ONLY STORES T/L 11/01/2019

United States

 Retailers (except food/ drug retailers)

             6,982,721

0.53%

Frontier Communications 1L TL-B

United States

 Telecommunications

             6,944,600

0.52%

CUMULUS MEDIA HOLDINGS T/L B 18/12/2020

United States

 Broadcast Radio & Television

             6,935,522

0.52%

TXU Energy 1L TL

United States

 Utilities

             6,806,975

0.51%

Virgin Media (fka NTL Investment Holdings Ltd) 1L TL-J  GBP

United Kingdom

 Cable & Satellite Television

             6,792,568

0.51%

Bass Pro Shops 1L TL-B

United States

 Retailers (except food/ drug retailers)

             6,778,943

0.51%

Multiplan  Inc. Term Loan B

United States

 Health Care

             6,745,707

0.51%

Doosan Infracore BOBCAT 1L TL-B

United States

 Industrial Equipment

             6,679,996

0.50%

BWAY Corporation 1L TL

United States

 Containers & Glass Products

             6,621,423

0.50%

MITCHELL INTL INC T/L B 01/10/2020

United States

 Business Equipment & Services

             6,585,025

0.50%

ON Semiconductor 1L TL

United States

 Electronics/Electrical

             6,557,689

0.50%

Berry Plastics 1L TL-I

United States

 Containers & Glass Products

             6,553,559

0.50%

 

 

 

          463,883,105

35.05%

 

                                                                                                                                                     

As at 31 December 2016, the below were the largest 50 investments based on the NAV:

 

Securities

Country

Industry

 Fair Value $

%

Valeant Pharmaceuticals T/L - F1

Canada

Drugs

33,740,844

2.67%

First Data T/L (2021C New Dollar)

United States

Business Equipment & Services

19,811,573

1.56%

Avago Technologies Tl

Cayman Islands

Electronics/Electrical

18,738,885

1.48%

Intelsat Jackson T/L B2 30/06/2019

Luxembourg

Telecommunications

14,692,419

1.16%

Endo Pharma T/L B-1

United States

Drugs

13,489,003

1.07%

Reynolds Group (Aka Beverage Packaging) T/L B-1 1St Lien

United States

Containers & Glass Products

12,641,463

1.00%

Emerald Expositions Hldg Tl B 12/06/2020

United States

Leisure Goods/Activities/Movies

12,280,768

0.97%

TXU/Tceh 10/16 Cov-Lite Tlb

United States

Utilities

11,768,911

0.93%

Scientific Games T/L B-2 17/09/2021

United States

Hotels & Casinos

11,271,791

0.89%

Petsmart Inc 1L Tl-B (First Lien)

United States

Retailers (except food/ drug retailers)

11,005,905

0.87%

Iasis Hlthcare Corp T/L B 03/05/2018

United States

Health Care

10,732,579

0.85%

Cablevision Systems Corp 1L Tl-B  (First-Lien)

United States

Cable & Satellite Television

10,217,556

0.81%

Energy Transfer Equity Tranche B T/L (First-Lien)

United States

Oil & Gas

10,103,973

0.80%

Burger King Corporation Term B (First-Lien) 30/09/2021

Canada

Food Service

9,968,943

0.79%

Dynegy Holdings Inc 1L Tl-B

United States

Utilities

9,928,505

0.78%

Univision Communication T/L C 01/03/2020

United States

Broadcast Radio & Television

9,895,718

0.78%

Pharmaceutical Product Development  Inc. T/L B

United States

Drugs

9,757,039

0.77%

Charter Communications Operating 5/16 Tli

United States

Cable & Satellite Television

9,592,959

0.76%

Wide Open West Finance Llc 1L Tl-B

United States

Cable & Satellite Television

9,507,862

0.75%

Chs/Community Health Incremental 2021 Term H Loan

United States

Health Care

9,502,553

0.75%

Presidio Inc T/L B

United States

Business Equipment & Services

9,442,600

0.75%

Tpf Ii Power Llc T/L B 11/09/2021

United States

Utilities

9,236,910

0.73%

99 Cents Only Stores T/L 11/01/2019

United States

Retailers (except food / drug retailers)

9,216,903

0.73%

Walter Inv Mang Corp New T/L 11/12/2020

United States

Financial Intermediaries

9,056,480

0.72%

Cowlitz Tribal Gaming Authority Term Loan B

United States

Hotels & Casinos

8,992,913

0.71%

On Semiconductor 1L Tl B

United States

Electronics/Electrical

8,748,268

0.69%

Bway Corporation 1L Tl-B  (First-Lien)

United States

Containers & Glass Products

8,735,720

0.69%

Information Res Inc T/L B 26/09/2020

United States

Business Equipment & Services

8,664,989

0.68%

Formula One Hldgs Ltd T/L 31/07/2021

Luxembourg

Leisure Goods/Activities/Movies

8,634,970

0.68%

Verallia Sa 1L Tl-B  Eur

France

Containers & Glass Products

8,585,594

0.68%

Bass Pro Shops 1L Tl-B

United States

Retailers (except food /drug retailers)

8,543,700

0.67%

Level 3 Communications T/L B4 15/01/2020

United States

Telecommunications

8,471,719

0.67%

Berlin Pckg 1St Ln Cov-Lt T/L 24/09/2021

United States

Containers & Glass Products

8,220,577

0.65%

HCA Inc. Term Loan B

United States

Health Care

8,213,308

0.65%

Michaels Stores T/L B1

United States

Retailers (except food/ drug retailers)

8,191,333

0.65%

Twin River Mgt Grp T/L B 1L 30/06/2020

United States

Hotels & Casinos

8,133,685

0.64%

Dtz Term B

United States

Building & Development

8,088,336

0.64%

Datatel-Sophia Lp Tl B (First-Lien)

United States

Electronics/Electrical

8,040,274

0.64%

Syniverse Holdings T/L 10/04/2019

United States

Telecommunications

7,921,118

0.63%

Talen Energy Supply Llc 4.625% 07/15/19 Sr:144A

United States

Utilities

7,598,950

0.60%

Zebra Technologies 1L T-B  (First-Lien)

United States

Electronics/Electrical

7,523,920

0.59%

Berry Plastics Tl

United States

Containers & Glass Products

7,391,542

0.58%

Dj Orthopedics Llc Tranche B-1 T/L (First-Lien)

United States

Health Care

7,013,498

0.55%

Multiplan  Inc. T/L B

United States

Health Care

7,004,501

0.55%

Jeld-Wen  Inc T/L 1 Usd

United States

Building & Development

6,884,458

0.54%

Acosta Holdco Inc  T/L 13/08/2021

United States

Business Equipment & Services

6,679,632

0.53%

Rexnord Corp 1L Tl-B

United States

Industrial Equipment

6,592,044

0.52%

Husky Injection Molding T/L 30/06/2021

Canada

Industrial Equipment

6,587,802

0.52%

Citycenter Holdings Llc T/L B 09/10/2020

United States

Hotels & Casinos

6,583,301

0.52%

Dell T/L B

United States

Electronics/Electrical

6,551,149

0.52%

 

 

 

498,199,443

39.36%

 

 

Unaudited Consolidated Statement of Operations

 

For the six months ended 30 June 2017

1 January 2017 to

30 June 2017

1 January 2016 to

31 December 2016

(Expressed in U.S. Dollars)

(Unaudited)

(Audited)

Income

 

 

Interest income (net of withholding taxes, 2017: $Nil; 2016: $Nil )

27,054,028

67,802,475

Other income from investments

805,331

1,047,152

Total income

27,859,359

68,849,627

 

 

 

Expenses

 

 

Investment management and services

4,797,345

10,664,024

Administration and professional fees

974,955

2,544,696

Directors' fees and travel expenses

119,393

258,827

Total expenses

5,891,693

13,467,547

 

 

 

Net investment income

21,967,666

55,382,080

 

 

 

Realised and unrealised gains and losses

 

 

Net realised loss on investments

(709,526)

(52,229,039)

Net realised  gain/(loss) on derivatives

63,070,504

(288,288,255)

Total net realised gain/(loss)

62,360,978

(340,517,294)

 

 

 

Net change in unrealised appreciation on investments

8,858,735

97,557,925

Net change in unrealised (depreciation)/appreciation on derivatives

(14,088,645)

48,360,316

Total net unrealised (depreciation)/appreciation

(5,229,910)

145,918,241

 

 

 

Realised and unrealised gain/(loss) on foreign currency

344,367

(2,123,380)

 

 

 

Net realised and unrealised gain/(loss)

57,475,435

(196,722,433)

 

 

 

Net increase/(decrease) in net assets resulting from operations

79,443,101

(141,340,353)

 

 

Unaudited Consolidated Statement of Changes in Net Assets

 

 

For the six months ended 30 June 2017

 

Ordinary Shares

(Expressed in U.S. Dollars)

 

(Unaudited)

Net assets as at 1 January 2017

 

1,266,042,532

Dividends

 

(23,270,363)

Share issue

 

1,658,319

Net movement from share buybacks and swaps

 

48,587

Net increase in net assets resulting from operations

 

79,443,101

Net assets as at 30 June 2017

 

1,323,922,176

 

 

 

31 December 2016

 

Ordinary Shares

(Expressed in U.S. Dollars)

 

(Audited)

Net assets as at 1 January 2016

 

1,714,972,853

Dividends

 

(63,223,857)

Net movement from share buybacks and swaps

 

(244,366,111)

Net decrease in net assets resulting from operations

 

(141,340,353)

Net assets as at 31 December 2016

 

1,266,042,532

 

 

Unaudited Consolidated Statement of Cash Flows

 

For the six months ended 30 June 2017

(Expressed in U.S. Dollars)

1 January 2017 to

30 June 2017

1 January 2016 to

31 December 2016

Cash flows from operating activities:

 

 

Net increase/(decrease) in net assets resulting from operations

79,443,101

(141,340,353)

Adjustment to reconcile net increase/(decrease)  in net assets resulting from operations to net cash (used in)/provided by operating activities:

 

 

Net realised loss on investments

709,526

52,229,039

Net change in unrealised depreciation /(appreciation) on investments and derivatives

5,229,910

(145,918,242)

Changes in receivables for investments sold

(33,079,517)

22,043,853

Changes in interest receivable

1,315,974

2,240,939

Changes in other receivables and prepayments

(54,359)

(18,680)

Changes in payables for investments purchased

814,417

(4,585,958)

Changes in payables to Investment Manager and affiliates

69,404

(1,012,887)

Changes in accrued expenses and other liabilities

(128,226)

(805,310)

Purchase of investments

(582,144,308)

(981,314,788)

Sale of investments

525,950,184

1,484,766,986

Net cash (used in)/provided by operating activities

(1,873,894)

286,284,599

 

 

 

 

 

 

Cash flows from financing activities:

 

 

Share issues

1,658,319

-

Net movement from share buybacks and swaps

48,587

(244,366,111)

Dividends paid

(23,270,363)

(63,223,857)

Net cash used in financing activities

(21,563,457)

(307,589,968)

 

 

 

Net decrease in cash and cash equivalents

(23,437,351)

(21,305,369)

 

 

 

Cash and cash equivalents at beginning of the period/year

58,829,626

80,134,995

 

 

 

Cash and cash equivalents at end of the period/year

35,392,275

58,829,626

 

 

Notes to the Unaudited Consolidated Interim Financial Statements 

 

For the period ended 30 June 2017

 

NOTE 1 - DESCRIPTION OF BUSINESS

 

The Company is a closed-ended investment company incorporated and registered in Guernsey with registered number 53155. It is a non-cellular company limited by shares and has been declared by the Guernsey Financial Services Commission to be a registered closed-ended collective investment scheme. On 20 April 2011, the Company was admitted to the Official List of the U.K. Listing Authority with a premium listing trading on the Main Market of the LSE.

 

On 30 September 2011, the Company raised an additional $187 million by means of a Placing and Offer for Subscription of C Shares and the shares were admitted to trading on the Main Market of the LSE on 5 October 2011. On 21 March 2013 and 24 October 2013, the Company raised an additional $550 million and $705 million by means of a Placing and Offer for Subscription of C Shares and the shares were admitted to trading on the Main Market of the LSE on 26 March 2013 and 29 October 2013 respectively. On 22 July 2013, through a tap issue, the Company raised gross proceeds of $69 million. The Sterling C Shares issued on 21 March 2013 were converted into 360,521,605 Sterling Ordinary Shares on 16 July 2013 and the Sterling Ordinary Shares issued on 24 October 2013 were converted into 421,103,481 Sterling Ordinary Shares on 21 January 2014.

 

At the AGM of the Company held in June 2017, the Directors were granted the general authority to purchase in the market up to 14.99% of the Ordinary Shares of each class in issue (as at 14 June 2017). This authority will expire at the next AGM in 2018. Pursuant to this authority, and subject to the Law and the discretion of the Directors, the Company may purchase shares of any of its classes in the market on an on-going basis with a view to addressing any imbalance between the supply of and demand for such shares, thereby increasing the NAV per share of the shares and assisting in managing the discount to NAV per share of the shares in relation to the price at which the shares of such class may be trading.

 

As required under Article 51 of the Company's Articles of Incorporation, an Extraordinary General Meeting ("EGM") was convened on 5 April 2017, being the sixth anniversary of the IPO admission date, to propose an ordinary resolution that the Company continues its business as a closed-ended investment company, which was duly passed. From 2018, a continuation vote will be proposed annually at the AGM.

 

The Company re-issued 1,630,000 U.S. Dollar Ordinary Shares from treasury in 12 tranches between 2 March 2017 and 5 May 2017.

 

The Company's investment objective is to provide its shareholders with regular dividends, at levels that are sustainable, whilst preserving the capital value of its investment portfolio, utilising the investment skills of the Investment Manager to pursue its investment objective. The Company invests mainly in floating rate senior secured loans issued in U.S. Dollars, Sterling and Euros by primarily North American and European Union corporations, partnerships and other business issuers. These loans will at the time of investment often be non-investment grade. The Company considers debt instruments to be non-investment grade if, at the time of investment, they are rated below the four highest categories (AAA, AA, A and BAA) by at least two independent credit rating agencies or, if unrated, are deemed by the Investment Manager to be of comparable quality.

 

For the purposes of efficient portfolio management, the Company has established a wholly-owned Luxembourg incorporated subsidiary, NB Global Floating Rate Income Fund (Lux) 1 S.à.r.l. which in turn holds a wholly-owned subsidiary, NB Global Floating Rate Income Fund (Lux) 2 S.à.r.l. All references to the Company in this document refer to the Company and its wholly owned Luxembourg subsidiaries. The directors of these companies are unrelated to the Directors of the Company.

 

The Company's share capital is denominated in Pound Sterling and U.S. Dollars and consists of Pound Sterling Ordinary Shares and U.S. Dollar Ordinary Shares as at 30 June 2017.

 

NOTE 2 - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

 

Basis of preparation

 

The accompanying Consolidated Financial Statements have been presented on a going concern basis and on the accrual basis of accounting in conformity with United States generally accepted accounting principles ("US GAAP"). The Company is regarded as an Investment Company and it follows the accounting and reporting requirements of the FASB ASC 946. The Board believes that the underlying assumptions are appropriate and that the Company's Consolidated Financial Statements therefore present a true and fair financial position.

 

Basis of consolidation

 

The Financial Statements comprise the financial statements of the Company and its wholly owned subsidiary undertakings as at 30 June 2017. The subsidiaries are NB Global Floating Rate Income Fund (Lux) 1 S.à.r.l.  and its wholly-owned subsidiary, NB Global Floating Rate Income Fund (Lux) 2 S.à.r.l. The Company and all its wholly owned subsidiaries have United States Dollars as their functional and reporting currency. The results of the subsidiary undertakings are included in the Unaudited Consolidated Statement of Operations. 

 

All intra-group balances, transactions, income and expenses are eliminated in full.

 

Use of estimates

 

The preparation of Financial Statements in conformity with US GAAP requires that the Directors make estimates and assumptions that affect the application of policies and reported amounts of assets and liabilities, income and expenses. Such estimates and associated assumptions are generally based on historical experience and various other factors that are believed to be reasonable under the circumstances, and form the basis of making the judgments about attributing values of assets and liabilities that are not readily apparent from other sources. Actual results may vary from such accounting estimates in amounts that may have a material impact on the financial information of the Company.

 

Revenue recognition

 

Interest earned on debt instruments is accounted for net of applicable withholding taxes and is recognised as income over the terms of the loans. Discounts received or premiums paid in connection with the acquisition of loans are amortised into interest income using the effective interest method over the contractual life of the related loan. If a loan pays off prior to maturity, the recognition of the fees and costs is accelerated as appropriate. The Company raises a provision when the collection of interest is deemed doubtful. 

 

Cash and cash equivalents

 

The Company's cash and cash equivalents comprise cash in hand and demand deposits and highly liquid investments with original maturities of less than 90 days that are both readily convertible to known amounts of cash and so near maturity that they represent insignificant risk of changes in value.

 

Valuation of investments

 

The Company carries investments on its Consolidated Statement of Assets and Liabilities at fair value in accordance with US GAAP, with changes in fair value recognised within the Consolidated Statement of Operations in each reporting period. Quoted investments are valued according to their bid price as at the close of the relevant reporting date. Investments in private securities are priced at the bid price using a pricing service for private loans. Asset backed securities are valued according to their bid price. If a price cannot be ascertained from the above sources, the Company will seek bid prices from third party broker/dealer quotes for the investments. The Investment Manager believes that bid price is the best estimate of fair value and is in line with the valuation policy adopted by the Company.

 

In cases where no third party price is available, or where the Investment Manager determines that the provided price is not an accurate representation of the fair value of the investment, the Investment Manager determines the valuation based on the Investment Manager's fair valuation policy. The overall criterion for fair value is a price at which the securities involved would change hands in a transaction between a willing buyer and a willing seller, neither being under compulsion to buy or sell and both having the same knowledge of the relevant facts.

 

Consistent with the above criterion, the following criteria are considered when applicable:

·      Valuation of other securities by the same issuer for which market quotations are available;

·      Reasons for absence of market quotations;

·      The credit quality of the issuer and the related economics;

·      Recent sales prices and/or bid and ask quotations for the security;

·      Value of similar securities of issuers in the same or similar industries for which market quotations are available;

·      Economic outlook of the industry;

·      Issuer's position in the industry;

·      The financial information of the issuer; and

·      The nature and duration of any restriction on disposition of the security.

 

Derivative financial instruments

 

The Company may, from time to time, hold derivative financial instruments for the purposes of hedging foreign currency exposure. These derivatives are measured at fair value in accordance with US GAAP, with changes in fair value recognised within the Unaudited Consolidated Statement of Operations in each reporting period. 

 

Depending on the product and the terms of the transaction, the fair value of the over the counter (OTC) derivative products, such as foreign exchange contracts, can be modelled taking into account the counterparties' credit worthiness and using a series of techniques, including simulation models.

 

Many pricing models do not entail material subjectivity because the methodologies employed do not necessitate significant judgments and the pricing inputs are observed from actively quoted markets. The forward exchange contracts valued by the Company using pricing models fall into this category and are categorised within level 2 of the fair value hierarchy.

 

As shares are denominated in U.S. Dollars and Pound Sterling and investments are denominated in U.S. Dollars, Euro or Sterling, holders of any class of shares are subject to foreign currency fluctuations between the currency in which such shares are denominated and the currency of the investments made by the Company. Consequently, the Investment Manager seeks to engage in currency hedging between the U.S. Dollar and any other currency in which the assets of the Company or a class of shares is denominated, subject to suitable hedging contracts such as forward currency exchange contracts being available in a timely manner and on terms acceptable to the Investment Manager, in their sole and absolute discretion. 

 

Note 5 details the gross and net derivative asset and liability position by contract type and the amount for those derivative contracts for which netting is permissible under US GAAP. The derivative assets and liabilities have been netted where an enforceable master netting arrangement is in place.

 

Realised gains and losses on investments

 

All investment transactions are recorded on a trade date basis. Upon sale or maturity, the difference between the consideration received and the cost of the investment is recognised as a realised gain or loss. The cost is determined based on the first in, first out ("FIFO") cost method.

 

Operating expenses

 

Operating expenses are recognised on an accruals basis. Operating expenses include amounts directly or indirectly incurred by the Company as part of its operations.

 

Currency translation

 

Monetary assets and liabilities denominated in a currency other than U.S. Dollars are translated into U.S. Dollar equivalents using spot rates as at the reporting period end date. On initial recognition, a foreign currency transaction is recorded and translated at the spot exchange rate at the transaction date. Non-monetary assets and liabilities are translated at the historic exchange rate. There were no non-monetary assets held during the period. Transactions during the period, including purchases and sales of securities, income and expenses, are translated at the rate of exchange prevailing on the date of the transaction. The rates of exchange against U.S. Dollars at 30 June 2017 were 1.29895 USD: 1GBP and 1.14055 USD: 1EUR (31 December 2016: 1.23565 USD: 1GBP and 1.05475 USD: 1EUR).

 

Buybacks cost

 

Any costs incurred by a share buyback will be charged to that share class.

 

Re-Issuance of Shares cost

 

Any costs incurred by a re-issue of shares held in treasury will be charged to that share class.

 

 

NOTE 3 - AGREEMENTS AND RELATED PARTIES

 

Investment Management Agreement

 

The Board is responsible for managing the business affairs of the Company but delegated certain functions to the Investment Manager under the Investment Management Agreement ("the Agreement") dated 18 March 2011.

 

The Manager of the Company is Neuberger Berman Europe Limited (which is a related party), an indirectly wholly owned subsidiary of the NB Group. On 17 July 2014, the Company, the Manager and Neuberger Berman Investment Advisers LLC (which was the Sub Investment Manager) made certain classificatory amendments to the Agreement for the purposes of the AIFM Directive.

 

The Sub-Investment Management Agreement was terminated on 17 July 2014 and the Sub-Investment Manager was appointed as the AIFM per the amended and restated IMA dated 17 July 2014. The Manager, Neuberger Berman Europe Limited, was appointed under the same agreement. In accordance with the terms of the IMA, the Manager shall pay a fee to the AIFM out of the investment management fee received from the Company. The Company does not pay any fees to the AIFM.

 

The AIFM is responsible for risk management and the discretionary management of the assets held in the Company's portfolio and will conduct the day-to-day management of the Company's assets (including un-invested cash). The AIFM is not required to and generally will not submit individual investment decisions for approval by the Board. The Manager provides certain administrative services to the Company.

 

As per the IMA dated 17 July 2014, the Manager is entitled to a management fee, which shall accrue daily, and be payable quarterly in arrears, at the following rate per annum of the Company's NAV:

 

On first £1bn of the NAV                                                              0.75%

On £1bn - £2bn of the NAV                                                         0.70%

Any amount greater than £2bn of the NAV                               0.65%

 

For the period ended 30 June 2017, the management fee expense was $4,797,345 (31 December 2016: $10,664,024), of which $2,434,729 (31 December 2016: $2,365,325) was unpaid at the period end.

 

The Manager is not entitled to a performance fee.

 

Administration, Custody and Company Secretary Agreement

 

Effective 1 March 2015, the Company entered into an Administration and Sub-Administrator agreement with U.S. Bancorp Fund Services (Guernsey) Limited ("Administrator") and Quintillion Limited ("Sub-Administrator"), both wholly owned subsidiaries of U.S. Bancorp. Under the terms of the agreement, Sub-Administration services are delegated to Quintillion Limited.

 

The Sub-Administrator is responsible, amongst other things, for the day-to-day administration of the Company (including but not limited to the calculation and publication of the estimated daily NAV).

 

The Administrator is entitled to an annual fee, accrued daily and paid monthly in arrears, in accordance with the schedule below and subject to an annual minimum of $75,000.

 

On first $250m of the NAV                                                                           0.05%

On $250m - $500m of the NAV                                                                  0.04%

On $500m - $1bn of the NAV                                                                      0.03%

Any amount greater than $1bn of the NAV                                               0.02%

 

For the period ended 30 June 2017, the administration fee was $265,562 (31 December 2016: $542,415) of which $43,889 (31 December 2016: $42,704) was unpaid at the period end.

 

Effective 14 June 2017, Carey Commercial Limited was appointed the Company Secretary in replacement of C.L. Secretaries Limited, a wholly owned subsidiary of Carey Commercial Limited. The Company Secretary is entitled to an annual fee of £78,300 plus out of pocket expenses.

 

For the period ended 30 June 2017, the secretarial fee was $66,808 (31 December 2016: $202,589), of which $8,618 related to administration of the re-issuance of U.S. Dollar Ordinary Shares, of which $19,632 (31 December 2016: prepaid of $6,020) was unpaid at the period-end.

 

Effective 1 March 2015, US Bank National Association ("Custodian") became the Custodian of the Company.

 

The Custodian is entitled to a fee of 0.025 per cent of the Market Value of the portfolio per annum, with a minimum annual fee of $25,000 in respect of portfolio and loan administration. For the period ended 30 June 2017, the custodian fee was $174,144 (31 December 2016: $416,006) of which $163,934 (31 December 2016: $262,470) was unpaid, all of which was due to US Bank National Association at the period end.

 

Registrar's Agreement

 

Capita Registrars (Guernsey) Limited has been appointed as registrar of the Company. The fee charged is at a rate of £2.00 per holder of shares appearing on the registry during the fee period, with a minimum charge per annum of £9,000. For the period ended 30 June 2017, the Registrars fees amounted to $54,395 (31 December 2016: $100,061). Of these, $8,304 (31 December 2016: $12,868) was unpaid at the period end.

 

NOTE 4 - RELATED PARTY TRANSACTIONS

 

Directors

 

The Directors are related parties and are remunerated for their services at a fee of £35,000 per annum (£45,000 for the Chairman). In addition, the Chairman of the Audit and Risk Committee receives an additional £5,000 for his services in this role. The Chairman of the Management Engagement Committee and the Chairman of the Remuneration Committee receive an additional £2,500 each per annum. The Directors' fee for the two Luxembourg subsidiaries, whose Directors are unrelated to the Guernsey Board members, amounts to €14,700 per annum per subsidiary. Of these, $17,400 were prepaid at the period end. For the period ended 30 June 2017, the Guernsey Directors' fees and travel expenses amounted to $120,423 (31 December 2016: $238,873). Of these, $ Nil were prepaid at the period end (31 December 2016: $ Nil). As at 30 June 2017, Mr Battey, Mrs Platts, Mr Dorey and Mr Frewen had 30,077, 10,069, 20,000 and 9,895 Sterling Ordinary Shares in the Company respectively (31 December 2016: Mr Battey, Mrs Platts, Mr Dorey and Mr Frewen 30,077,10,069, 20,000 and 9,895 Sterling Ordinary Shares in the Company respectively).

 

Neuberger Berman Europe Limited and Neuberger Berman Investment Advisers LLC

 

The contracts with Neuberger Berman Europe Limited and Neuberger Berman Investment Advisers LLC are classified as related party transactions. Other than fees payable in the ordinary course of business and the additional fees disclosed in Note 3, there have been no material transactions with related parties, which have affected the financial position or performance of the Company in the financial period.

 

NOTE 5 - FAIR VALUE OF FINANCIAL INSTRUMENTS

 

A financial instrument is defined by FASB ASC 825, Disclosures about Fair Value of Financial Instruments, as cash, evidence of an ownership interest in an entity, or a contract that creates a contractual obligation or right to deliver to or receive cash or another financial instrument from a second entity on potentially favourable terms. Fair value estimates are made at a discrete point in time, based on relevant market data, information about the financial instruments, and other factors.

 

Fair value was determined using available market information and appropriate valuation methodologies. Estimates of fair value of financial instruments without quoted market prices are subjective in nature and involve various assumptions and estimates that are matters of judgment. Accordingly, fair values are not necessarily indicative of the amounts realised on disposition of financial instruments. The use of different market assumptions and/or estimation methodologies may have a material effect on estimated fair value amounts.

 

The following estimates and assumptions were used at 30 June 2017 to estimate the fair value of each class of financial instruments:

 

-        Valuation of financial investments - The loans and bonds are valued at bid price. The Investment Manager believes that bid price is the best estimate of fair value and is in line with the valuation policy adopted by the Company.

 

-        Cash and cash equivalents - The net realisable value is a reasonable estimate of fair value due to the short-term nature of these instruments.

 

-        Receivables for investments sold - The net realisable value reasonably approximates fair value as they reflect the value at which investments are sold to a willing buyer and settlement period on their balances is short term.

 

-        Interest receivables - The net realisable value reasonably approximates fair value.

 

-        Other receivables and prepayments - The net realisable value reasonably approximates fair value.

 

-        Derivatives - The Company estimates fair values of derivatives based on the latest available forward exchange rates.

 

-        Payables for investments purchased - The net realisable value reasonably approximates fair value as they reflect the value at which investments are purchased from a willing seller and settlement period on their balances is short term.

 

-        Payables to the Investment Manager and affiliates - The net realisable value reasonably approximate fair value.

 

-        Accrued expenses and other liabilities - The net realisable value reasonably approximates fair value.

 

A fair value hierarchy that prioritises the inputs to valuation techniques used to measure fair value is established under FASB ASC Topic 820. The objective of a fair value measurement is to determine the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date (an exit price). Accordingly, the fair value hierarchy gives the highest priority to valuations based upon unadjusted quoted prices in active markets for identical assets or liabilities (Level 1) and the lowest priority to valuations based upon unobservable inputs that are significant to the valuation (Level 3). The levels of the fair value hierarchy under FASB ASC Topic 820-10-35-39 to 55 are as below:

 

The guidance establishes three levels of the fair value hierarchy as follows:

 

Level 1: price quotations in active markets/exchanges for identical securities;

 

Level 2: other observable inputs (including but not limited to: quoted prices for similar assets or liabilities in markets that are not active, inputs other than quoted prices that are observable for the assets or liabilities (such as interest rates, yield curves, volatilities, prepayment speeds, loss severities, credit risks and default rates) or other market-corroborated inputs); and

 

Level 3: unobservable inputs based on the best information available in the circumstance, to the extent observable inputs are not available (including the Company's own assumption used in determining the fair value of investments).

 

The Company has adopted the authoritative guidance contained in FASB ASC 820-10, Fair Value Measurements and Disclosures, for estimating the fair value of the financial instruments that have calculated NAV per share in accordance with FASB ASC 946-10.

 

The inputs or methodology used for valuing securities are not necessarily an indication of the risk associated with investing in those securities.

 

 

The following table details the Company's financial instruments that were accounted for at fair value as at 30 June 2017.

 

Financial Instruments at Fair Value as at 30 June 2017

Financial investments

 

Level 1 ($)

Level 2 ($)

Level 3 ($)

Total ($)

Floating rate senior secured loans

 

-

1,177,904,805

49,049,334

1,226,954,139

Fixed rate bonds/corporate loans

 

-

56,325,844

-

56,325,844

Floating rate bonds/corporate loans

 

-

37,949,573

-

37,949,573

Total financial investments

 

-

1,272,180,222

49,049,334

1,321,229,556

 

 

 

 

 

 

 

 

 

Level 1 ($)

Level 2 ($)

Level 3 ($)

Total ($)

Balance at start of the period

 

-

1,204,755,476

52,130,747

1,256,886,223

Purchases during the period5

 

-

866,838,270

12,741,929

879,580,199

Sales during the period5

 

-

(801,206,821)

(22,179,253)

(823,386,074)

Realised loss on investments

 

-

(826,998)

117,472

(709,526)

Unrealised gain on revaluation

 

-

9,070,549

(211,815)

8,858,734

Transfer from Level 2 to Level 3

 

-

(28,796,357)

28,796,357

-

Transfer from Level 3 to Level 2

 

-

22,346,103

(22,346,103)

-

Balance at end of the year

 

-

1,272,180,222

49,049,334

1,321,229,556

 

5 Included in this figure is $297,435,890 of non-cash transactions. These arose due to the repricing and restructuring of certain investments during the period. These have also been excluded from the sales and purchases in the Unaudited Consolidated Statement of Cash Flows table for the six months ended 30 June 2017.

 

 

 

 

Level 1 ($)

Level 2 ($)

Level 3 ($)

Total ($)

Financial assets

No. of contracts

 

 

 

 

Derivatives (for hedging purposes only)

12

-

2,098,135

-

2,098,135

Financial liabilities

 

 

 

 

 

Derivatives (for hedging purposes only)

12

-

(961,634)

-

(961,634)

Total

24

-

1,136,501

-

1,136,501

 

Financial Instruments at Fair Value as at 31 December 2016

Financial investments

 

Level 1 ($)

Level 2 ($)

Level 3 ($)

Total ($)

Floating rate senior secured loans

 

-

1,161,742,705

52,130,747

1,213,873,452

Fixed rate bonds/corporate loans

 

-

6,410,344

-

6,410,344

Floating rate bonds/corporate loans

 

-

36,602,427

-

36,602,427

Total financial investments

 

-

1,204,755,476

52,130,747

1,256,886,223

 

 

 

Level 1 ($)

Level 2 ($)

Level 3 ($)

Total ($)

Balance at start of the year

 

-

1,669,812,289

45,197,246

1,715,009,535

Purchases during the year

 

-

950,168,859

31,145,929

981,314,788

Sales during the year

 

-

(1,453,052,585)

(31,714,401)

(1,484,766,986)

Realised loss on investments

 

-

(46,603,485)

(5,625,554)

(52,229,039)

Unrealised gain on revaluation

 

-

86,491,473

11,066,452

97,557,925

Transfer from Level 2 to Level 3

 

-

(54,881,616)

54,881,616

-

Transfer from Level 3 to Level 2

 

-

52,820,541

(52,820,541)

-

Balance at end of the year

 

-

1,204,755,476

52,130,747

1,256,886,223

Financial assets

No of contracts

Level 1 ($)

Level 2 ($)

Level 3 ($)

Total ($)

Derivatives (for hedging purposes only)

15

-

15,225,146

-

15,225,146

Financial liabilities

 

 

 

 

 

Derivatives (for hedging purposes only)

15

-

-

-

-

Total

30

-

15,225,146

-

15,225,146

 

The derivatives assets and liabilities are offset in accordance with the guidance in sections 210-20-45 and 815-10-45 to determine the net amounts presented in the Consolidated Statement of Assets and Liabilities. All derivative trades have an enforceable master netting agreement so the net amount based on this is the same as the net amount disclosed in the Consolidated Statement of Assets and Liabilities. As at 30 June 2017, there were two counterparties for the forward contracts (31 December 2016: two).
 

 

Due to changes in observable inputs, the Company transferred securities from Level 2 to Level 3 and from Level 3 to Level 2 of the fair value hierarchy. Level 3 assets are valued using single broker quotes.

 

The following table presents the impact of derivative instruments on the Unaudited Consolidated Statement of Operations in conformity with US GAAP.

 

Primary underlying risk

For the period ended

30 June 2017 ($)

For the year ended

31 December 2016 ($)

Net realised gain/(loss) on derivatives

63,070,504

(288,288,255)

Net change in unrealised (depreciation)/ appreciation on derivatives

(14,088,645)

48,360,316

Total

48,981,859

(239,927,939)

 

Primary underlying risks (credit risk, liquidity risk and market risk) associated with the derivatives are explained in Note 6.

 

There is no collateral for forward contracts.

 

The Company presents the gain or loss on derivatives in the Unaudited Consolidated Statement of Operations.

 

The Company uses independent third party vendors to price its portfolio. As part of its valuation process, the AIFM evaluates the number of broker quotes that combine to make up the valuation provided by these vendors and if it believes that the number of broker quotes is not sufficient to ensure a Level 2 price it designates those positions Level 3. As at 30 June 2017 the AIFM designated 17 (31 December 2016: 16) of its floating rate senior secured loans at Level 3.

 

NOTE 6 - RISKS

 

The Company is subject to various risks, including, but not limited to, market risk, foreign exchange risk, credit risk, geographic concentration risk and liquidity risk. The Investment Manager attempts to monitor and manage these risks on an ongoing basis. 

 

Market Risk

Market risk is the potential for changes in the value of investments. Market risk includes interest rate risk, foreign exchange risk and price risk. Interest rate risk primarily results from exposures to changes in the level, slope and curvature of the yield curve, the volatility of interest rates and credit spreads. Floating rate investments, such as senior secured loans, typically receive a fixed coupon, which is linked to a variable base rate, usually LIBOR or EURIBOR. As such, income earned will be affected by changes in the variable component albeit downward moves are likely to be capped by the LIBOR/EURIBOR floors that are prevalent in the majority of transactions. The Company invests predominantly in floating rate investments; however, it does have some exposure to fixed rate investments, which are subject to interest rate risk through movements in their market price when interest rates change.

 

Price Risk is the risk that the price of the security will fall. The Investment Manager manages the exposure to price risk by diversifying the portfolio.

 

Foreign Exchange Risk arises from various currency exposures, primarily with respect to Sterling and Euro investments and share issue proceeds. The Company makes use of hedging techniques, as part of its risk management strategy, including but not limited to the use of forward exchange contracts to mitigate its exposure to this risk. These instruments involve market risk, credit risk, or both kinds of risks. Risks arise from the possible inability of counterparties to meet the terms of their contracts and from movement in currency and interest rates.

 

Credit Risk

The Company maintains positions in a variety of securities, derivative financial instruments and cash and cash equivalents in accordance with its investment strategy and guidelines. The Company's trading activities expose the Company to counterparty credit risk from brokers, dealers and other financial institutions (collectively, "counterparties") with which it transacts business. "Counterparty credit risk" is the risk that a counterparty to a trade will fail to meet an obligation that it has entered into with the Company, resulting in a financial loss to the Company. The Company's policy with respect to counterparty credit risk is to minimize its exposure to counterparties with perceived higher risk of default by dealing only with counterparties that meet the credit standards set out by the Investment Manager.

 

All the Company's assets other than derivative financial instruments were held by the Custodian. The Custodian segregates the assets of the Company from the Custodian's assets and other Custodian clients. The Investment Manager believes the risk is low with respect to any losses as a result of this concentration. The Company conducts its trading activities with respect to non-derivative positions with a number of counterparties.  Counterparty credit risk borne by these transactions is mitigated by trading with multiple counterparties.

 

In addition, the Company trades in over-the-counter ("OTC") derivative instruments. The Company is subject to counterparty credit risk related to the potential inability of counterparties to these derivative transactions to perform their obligations to the Company. The Company's exposure to counterparty credit risk associated with counterparty nonperformance is generally limited to the fair value (derivative assets and liabilities) of OTC derivatives reported as net assets, net of collateral received or paid, pursuant to agreements with each counterparty.

 

The Investment Manager attempts to reduce the counterparty credit risk of the Company by establishing certain credit terms in its ISDA Master Agreements (with netting terms) with counterparties, and through credit policies and monitoring procedures. Under ISDA Master Agreements in certain circumstances (e.g., when a credit event such as a default occurs) all outstanding transactions under the agreement are terminated, the termination value is assessed and only a single net amount is due or payable in settlement of all transactions. The Company receives and gives collateral in the form of cash and marketable securities and it is subject to the ISDA Master Agreement Credit Support Annex. This means that securities received/given as collateral can be pledged or sold during the term of the transaction. The terms also give each party the right to terminate the related transactions on the other party's failure to post collateral.

 

The Company may invest in a range of bank debt investments and corporate and other bonds. Until such investments are sold or are paid in full at maturity, the Company is exposed to issuer credit risk, relating to whether the issuer will make interest and/or principal payments on their debt obligations.

 

Geographic Concentration Risk

The Company may invest a relatively large percentage of its assets in issuers located in a single country, a small number of countries, or a particular geographic region. As a result, the Company's performance may be closely aligned with the market, currency or economic, political or regulatory conditions and developments in those countries or that region, and could be more volatile than the performance of more geographically diversified investments.

 

Liquidity Risk

Liquidity risk is the risk that the Company will not be able to meet its obligations as and when these fall due. Liquidity risk is managed by the Investment Manager to ensure that the Company maintains sufficient working capital in cash or near cash form so as to be able to meet the Company's ongoing requirements as they fall due.

 

Participation Commitments

With respect to the senior loans the Company may: 1) invest in assignments; 2) act as a participant in primary lending syndicates; or 3) invest in participations. If a Company purchases a participation of a senior loan interest, the Company would typically enter into a contractual agreement with the lender or other third party selling the participation, rather than directly with the borrower. As such, the Company not only assumes the credit risk of the borrower, but also that of the selling participant or other persons inter positioned between the Company and the borrower. As of 30 June 2017, there were no such outstanding participation commitments in the Company.

 

Other Risks

Legal, tax and regulatory changes could occur during the term of the Company that may adversely affect the Company. The regulatory environment for alternative investment companies is evolving, and changes in the regulation of investment companies may adversely affect the value of investments held by the Company or the ability of the Company to pursue its trading strategies. The effect of any future regulatory change on the Company could be substantial and adverse. The Board has considered the specific risks faced by the Company as a result of Brexit. At the portfolio level, the Board expects the impact of Brexit to be limited given the hedging arrangements in place and the robust investment process the Investment Manager has always adopted and its positioning in better rated, performing issuers. At the Company level the impact could be felt more directly through volatility of the Company's share price. The Board seeks to mitigate this risk by continuing to address any imbalances in supply and demand of the Company's shares through the use of further share buybacks in line with its stated policy.

 

NOTE 7 - INCOME TAXES

 

The Company is exempt from Guernsey tax on income derived from non-Guernsey sources. However, certain of its underlying investments may generate income that is subject to tax in other jurisdictions, principally in the United States. The Company files tax returns for its Luxembourg entities.

 

In accordance with US GAAP, management is required to determine whether a tax position of the Company is more likely than not to be sustained upon examination by the applicable taxing authority, including resolution of any related appeals or litigation processes, based on the technical merits of the position. The tax benefit to be recognised is measured as the largest amount of benefit that it has 50% or higher chance of being realised upon ultimate settlement. De-recognition of a tax benefit previously recognised could result in the Company recording a tax liability that would reduce net assets. This policy also provides guidance on thresholds, measurement, de-recognition, classification, interest and penalties, accounting in periods, disclosure, and transition that intends to provide better financial statement comparability among different entities.

 

As of 30 June 2017, the Company has recorded no liability for net unrecognised tax benefits relating to uncertain tax positions it has taken or expects to take in future tax returns (31 December 2016: Nil).

 

 

NOTE 8 - FINANCIAL HIGHLIGHTS

 

30 June 2017

Per share operating performance

U.S. Dollar

Ordinary Share as at 30 June 2017 ($)

Sterling

Ordinary Share as at

30 June 2017 (£)

 

 

 

NAV per share at the beginning of the period

0.9881

0.9787

 

Shareholder activity during the period

0.0012

-

 

 

 

 

 

Income from investment operations (a)

 

 

 

Net income per share for the period (b)

0.0165

0.0167

 

Net realised and unrealised loss from investments

(0.0001)

(0.0002)

 

Foreign currency translation

-

(0.0038)

 

Total gain from operations

0.0164

0.0127

 

Distribution per share during the period

(0.0174)

(0.0177)

 

NAV per share at the end of the period

0.9883

0.9737

 

 

 

 

 

Total return6 (b)

 

 

 

Total return6

1.81%

1.27%

 

 

 

 

 

Ratios to average net assets (b)

 

 

 

Net investment income

1.67%

1.71%

 

Expenses

(0.49%)

(0.46%)

 

 

(a) Average shares outstanding were used for calculation.

(b) An individual shareholder's return may vary from these returns based on the timing of the shareholder's investments in the Company.

 

6The total return is the NAV return per share plus dividends paid during the period. This figure is for the period ended 30 June 2017.

 

31 December 2016

 

U.S. Dollar

Ordinary Share as at 31 December 2016 ($)

Sterling

Ordinary Share as at

31 December 2016 (£)

Per share operating performance

 

 

NAV per share at the beginning of the year

0.9490

0.9422

Shareholder activity during the year

0.0089

0.0094

 

 

 

Income from investment operations (a)

 

 

Net income per share for the year (b)

0.0376

0.0373

Net realised and unrealised gain from investments

0.0356

0.0357

Foreign currency translation

-

(0.0034)

Total gain from operations

0.0732

0.0696

Distribution per share during the year

(0.0430)

(0.0425)

Net asset value per share at the end of the year

0.9881

0.9787

 

Total return7 (b)

 

 

Total return7

8.41%

8.17%

 

 

 

Ratios to average net assets (b)

 

 

Net investment income

3.91%

3.90%

Expenses

(0.93%)

(0.95%)

 

(a) Average shares outstanding were used for calculation.

(b) An individual shareholder's return may vary from these returns based on the timing of the shareholder's investments in the Company.

 

7 The total return is the NAV return per share plus dividends paid during the year. This figure is for the year to 31 December 2016.

 

NOTE 9 - SHARE CAPITAL

 

The share capital of the Company consists of an unlimited number of Ordinary Shares of no par value, which upon issue the Directors may classify as:

 

(i) U.S. Dollar Ordinary Shares, Sterling Ordinary Shares or Euro Ordinary Shares or as shares of such other classes as the Directors may determine;

 

(ii) B Shares of such classes denominated in such currencies as the Directors may determine; and

 

(iii) C Shares of such classes denominated in such currencies as the Directors may determine.

 

 

The rights attached to the above shares are one vote in respect of each share held and, in the case of a general meeting of all shareholders:

 

(a)  One vote in respect of each U.S. Dollar Ordinary Share held by the shareholder;

 

(b)  1.6 votes in respect of each Sterling Ordinary Share held by the shareholder; and

 

(c)  In respect of a Share of a class denominated in any currency other than U.S. Dollars or Sterling held by the shareholder, such number of votes per Share of such class as shall be determined by the Directors in their absolute discretion upon the issue for the first time of shares of the relevant class.

 

 

The Directors may effect distributions of capital proceeds attributable to the Ordinary Shares to holders of Ordinary Shares by issuing B Shares of a particular class to holders of Ordinary Shares of a particular class pro-rata to their holding of Ordinary Shares of such class.

 

The B Shares are issued on terms that each B Share shall be compulsorily redeemed by the Company shortly following issue and the redemption proceeds paid to the holders of such B Shares on such terms and in such manner as the Directors may from time to time determine.

 

The Directors are authorised to issue C Shares of such classes (and denominated in such currencies) as they may determine in accordance with Article 4 and with C Shares of each such class being convertible into Ordinary Shares of such class as the Directors may determine at the time of issue of such C Shares.

 

The C Shares will not carry the right to attend and receive notice of any general meetings of the Company, nor will they carry the right to vote at such meetings.

 

The C Shares will be entitled to participate in a winding-up of the Company or on a return of capital in relation to the C share surplus as defined in the Prospectus.

 

The C Shares will be entitled to receive such dividends as the Directors may resolve to pay to such holders out of the assets attributable to such class of C Shares.

 

There were no Euro Ordinary Shares in issue as at 30 June 2017 (31 December 2016: none).

 

 

As at 30 June 2017, there were no C Shares in issue (31 December 2016: none).

 

From 1 January 2017 to 30 June 2017

U.S. Dollar Ordinary Shares

Sterling

Ordinary Shares

 

Total

Balance as at 1 January 2017

38,270,109

1,015,614,330

1,053,884,439

Monthly conversions8

4,486,391

(3,544,554)

941,837

Share issuance (out of Treasury)

1,630,000

-

1,630,000

Share buybacks

-

-

-

Balance as at 30 June 20179

44,386,500

1,012,069,776

1,056,456,276

 

From 1 January 2016 to 31 December 2016

U.S. Dollar Ordinary Shares

Sterling

Ordinary Shares

 

Total

Balance as at 1 January 2016

52,380,402

1,199,095,966

1,251,476,368

Monthly conversions8

(8,444,322)

4,357,949

(4,086,373)

Share buybacks

(5,665,971)

(187,839,585)

(193,505,556)

Balance as at 31 December 20169

38,270,109

1,015,614,330

1,053,884,439

 

8 The Company offers a monthly conversion facility pursuant to which shareholders may elect to convert some or all of their shares of a class into shares of any other class.

9 Balance of issued shares (less Treasury shares) used to calculate NAV.

 

Treasury Shares

 

As at 30 June 2017, the Company held the following shares in treasury.

 

 

30 June 2017

 31 December 2016

Sterling Ordinary Treasury Shares10

 

75,000,000

75,000,000

U.S. Dollar Ordinary Treasury Shares10

 

1,342,627

2,972,627

 

 

10The Company has an approved share buyback programme and may elect to buyback ordinary shares at certain times during the period for either cancellation or to be held as Treasury shares. During the period, the Company has not repurchased any shares to be held in Treasury or for cancellation.

 

 

The Company has issued 1,630,000 USD Dollar Ordinary Shares out of Treasury during the period.

 

 

NOTE 10 - SUBSEQUENT EVENTS

 

Since the period ended 30 June 2017 and up the last practicable date prior to publishing, the Company has repurchased 6,175,954 Sterling Ordinary Shares and 334,649 US Dollar Ordinary Shares for cancellation.

 

There were no other subsequent events in the period ended 30 June 2017.

 

NOTE 11 - DIVIDENDS

 

The following dividends were declared for shareholders of Ordinary and C Shares since inception:

 

Period

Date Declared

Payment Date

Dividend per U.S. Dollar Share

Dividend per Sterling Share

Period 20 April 2011 to 30 September 2011

12 October 2011

9 December 2011

$0.01486

£0.01486

Quarter ended 31 December 2011

5 January 2012

24 February 2012

$0.01187

£0.01187

Quarter ended 31 December 2011- C Shares

5 January 2012

24 February 2012

$0.00323

£0.00323

Quarter ended 31 March 2012

12 April 2012

25 May 2012

$0.01260

£0.01260

Quarter ended 30 June 2012

5 July 2012

24 August 2012

$0.01310

£0.01310

Quarter ended 30 September 2012

3 October 2012

23 November 2012

$0.01210

£0.01210

Quarter ended 31 December 2012

9 January 2013

22 February 2013

$0.01160

£0.01160

Quarter ended 31 March 2013

8 April 2013

24 May 2013

$0.01220

£0.01220

Quarter ended 30 June 2013

4 July 2013

16 August 2013

$0.01110

£0.01110

Quarter ended 30 June 2013 - C Shares

4 July 2013

26 July 2013

-

£0.00550

Quarter ended 30 September 2013

7 October 2013

22 November 2013

$0.00890

£0.00890

Quarter ended 31 December 2013

6 January 2014

21 February 2014

$0.00940

£0.00940

Quarter ended 31 December 2013 - C Shares

6 January 2014

7 February 2014

-

£0.00200

Quarter ended 31 March 2014

4 April 2014

27 May 2014

$0.00860

£0.00860

Quarter ended 30 June 2014

3 July 2014

15 August 2014

$0.00890

£0.00890

Quarter ended 30 September 2014

3 October 2014

21 November 2014

$0.00950

£0.00950

Quarter ended 31 December 2014

7 January 2015

20 February 2015

$0.00960

£0.00960

Quarter ended 31 March 2015

7 April 2015

26 May 2015

$0.00890

£0.00890

Quarter ended 30 June 2015

3 July 2015

15 August 2015

$0.01030

£0.01030

Quarter ended 30 September 2015

5 October 2015

23 October 2015

$0.00910

£0.00910

Quarter ended 31 December 2015

6 January 2016

19 February 2016

$0.00990

£0.00990

Quarter ended 31 March 2016

5 April 2016

25 May 2016

$0.01030

£0.01030

Quarter ended 30 June 2016

6 July 2016

19 August 2016

$0.01080

£0.01080

Quarter ended 30 September 2016

05 October 2016

17 November 2016

$0.01100

£0.01090

Quarter ended 31 December 2016

05 January 2017

17 February 2017

$0.00860

£0.00850

Quarter ended 31 March 2017

05 April 2017

23 May 2017

$0.00910

£0.00900

Quarter ended 30 June 2017

05 July 2017

18 August 2017

$0.00860

£0.00840

 

The Company has issued the following Ordinary Shares under Scrip Dividend Alternative since inception:

 

 

Period

Number of U.S. Dollar

Ordinary

Shares

Number of Sterling

Ordinary

Shares

Rate per U.S. Dollar Ordinary Share

Rate per Sterling Ordinary Share

Quarter ended 30 September 2011

91,565

710,833

$0.95880

£0.96320

Quarter ended 31 December 2011

68,398

592,380

$0.95300

£0.95760

Quarter ended 31 March 2012

84,444

14,653

$0.99300

£1.00020

Quarter ended 30 June 2012

97,572

792,651

$0.97840

£0.97160

Quarter ended 30 September 2012

91,479

567,376

$1.00400

£0.99030

Quarter ended 31 December 2012

29,500

821,100

$1.02000

£1.00650

Quarter ended 31 March 2013

69,213

38,805

$1.05700

£1.05080

Quarter ended 30 June 2013

28,237

221,317

$1.06700

£1.03880

Quarter ended 30 September 2013

58,190

365,543

$1.03870

£1.03360

Quarter ended 31 December 2013

67,590

217,354

$1.06900

£1.04880

Quarter ended 31 March 2014

67,228

668,002

$1.03950

£0.99010

Quarter ended 30 June 2014

27,941

341,872

$1.00280

£0.99390

Quarter ended 30 September 2014

28,942

233,785

$0.98230

£0.97500

Quarter ended 31 December 2014

30,277

181,999

$0.99520

£0.97040

Quarter ended 31 March 2015

23,310

202,637

$0.99600

£0.98790

Quarter ended 30 June 2015

6,507

609,773

$0.98890

£0.98110

Quarter ended 30 September 2015

5,231

50,620

$0.96770

£0.96010

 

The Board decided to replace the Scrip Dividend option with a Dividend Re-investment Plan, whereby the shareholders have the option to re-invest their cash dividend in the Company's shares on an efficient basis.

 

 

NOTE 12 - OTHER

 

The Company has determined that no accrual or loss contingency is required in the consolidated financial statements.

 

 

Additional Information

 

Contact details

 

Directors

 

William Frewen (Chairman)

Sandra Platts

Richard Battey

Rupert Dorey

 

All c/o the Company's registered office.

 

 

 

 

 

Registered Office

 

1st & 2nd Floors, Elizabeth House

Les Ruettes Brayes

St Peter Port

Guernsey

GY1 1EW

Alternative Investment Fund Manager

 

Neuberger Berman Investment Advisers LLC

190 S LaSalle Street

Chicago

IL 60603

United States of America

 

Manager

 

Neuberger Berman Europe Limited

4th Floor, 57 Berkeley Square

London

United Kingdom

W1J 6ER

 

Designated Administrator

 

U.S. Bancorp Fund Services (Guernsey), Limited

1st Floor

Tudor House

Le Bordage

St Peter Port

Guernsey

GY1 1DB

 

Sub-Administrator

 

Quintillion

24/26 City Quay

Dublin

Ireland

 

 

 

                          

Custodian and Principal Bankers

 

US Bank National Association

214 North Tryon Street

26th Floor, Charlotte

North Carolina 28202

United States of America

 

Company Secretary

 

Carey Commercial Limited

(Formerly C.L. Secretaries Limited)

1st & 2nd Floors, Elizabeth House

Les Ruettes Brayes

St Peter Port

Guernsey

GY1 1EW

 

Joint Financial Adviser and Joint Corporate Broker

 

Stifel Nicolaus Europe Limited

150 Cheapside

London

United Kingdom

EC2V 6ET

 

Joint Financial Adviser and Joint Corporate Broker

 

Fidante Capital

1 Tudor Street

London

United Kingdom

EC4Y 0AH

 

Solicitors to the Company (as to English law and U.S. securities law)

 

Herbert Smith Freehills LLP
Exchange House
Primrose Street
London

United Kingdom

EC2A 2EG

 

Advocates to the Company (as to Guernsey law)

 

Carey Olsen

PO Box 98

Carey House

Les Banques

St. Peter Port

Guernsey

GY1 4BZ

 

Independent Auditors

 

PricewaterhouseCoopers CI LLP

Royal Bank Place

1 Glategny Esplanade

St. Peter Port

Guernsey

GY1 4ND

Registrar

 

Capita Registrars (Guernsey) Limited

Mont Crevelt House

Bulwer Avenue

St. Sampson

Guernsey

GY2 4LH

 

 


This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
IR BLGDIRSBBGRL
UK 100

Latest directors dealings